Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Mino-Kenudson, Mari

Class:IdPerson:9701738
_displayNameMino-Kenudson, Mari
_timestamp2020-09-28 00:17:07
created[InstanceEdit:9701744] Rothfels, Karen, 2020-09-28
firstnameMari
initialM
surnameMino-Kenudson
(author)[LiteratureReference:9701740] Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers
[LiteratureReference:9713917] Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
[LiteratureReference:9714001] Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
[Change default viewing format]
No pathways have been reviewed or authored by Mino-Kenudson, Mari (9701738)